In line with literature, we also analyzed and observed high blood levels of CXCL10 and CXCL8 in DCM patients and we investigated them as potential pharmacological targets at systemic and local level, rather than disease predictors. The gene discussed is CXCL10; the disease is familial dilated cardiomyopathy.